Volume 19, Number 12—December 2013
CME ACTIVITY - Synopsis
Epidemiologic Investigations into Outbreaks of Rift Valley Fever in Humans, South Africa, 2008–2011
Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at www.medscape.org/journal/eid; (4) view/print certificate.
Release date: November 21, 2013; Expiration date: November 21, 2014
Upon completion of this activity, participants will be able to:
• Evaluate the general epidemiology and clinical consequences of Rift Valley fever (RVF)
• Assess temporal trends and demographics for infections with RVF
• Distinguish the most common exposure among patients with RVF in the current study
• Analyze specific risk factors for RVF associated with animal care.
Cathy Young, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Cathy Young has disclosed no relevant financial relationships.
Charles P. Vega, MD, Health Sciences Clinical Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.
Disclosures: Brett N. Archer, Juno Thomas, Jacqueline Weyer, Ayanda Cengimbo, Dadja E. Landoh, Charlene Jacobs, Sindile Ntuli, Motshabi Modise, Moshe Mathonsi, Morton S. Mashishi, Patricia A. Leman, Chantel le Roux, Petrus Jansen van Vuren, Alan Kemp, and Janusz T. Paweska have disclosed no relevant financial relationships. Lucille Blumberg has disclosed the following relevant financial relationships: served as an advisor or consultant for Pfizer; served as a speaker or a member of a speakers bureau for GlaxoSmithKline; received grants for clinical research from Sanofi Pasteur
- Page created: December 11, 2013
- Page last updated: December 11, 2013
- Page last reviewed: December 11, 2013
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)